Literature DB >> 19954913

Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes.

Anna Linda1, Marco Trovo, Jeffrey D Bradley.   

Abstract

Stereotactic body radiation therapy (SBRT) is a new radiotherapy treatment method that has been applied to the treatment of Stage I lung cancers in medically inoperable patients, with excellent clinical results. SBRT allows the delivery of a very high radiation dose to the target volume, while minimizing the dose to the adjacent normal tissues. As a consequence, CT findings after SBRT have different appearance, geographic extent and progression timeline compared to those following conventional radiation therapy for lung cancer. In particular, SBRT-induced changes are limited to the "shell" of normal tissue outside the tumor and have a complex shape. When SBRT-induced CT changes have a consolidation/mass-like appearance, the differentiation from tumor recurrence can be very difficult. An understanding of SBRT technique as it relates to the development of SBRT-induced lung injury and familiarity with the full spectrum of CT manifestations are important to facilitate diagnosis and management of lung cancer patients treated with this newly emerging radiotherapy method.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19954913     DOI: 10.1016/j.ejrad.2009.10.029

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  27 in total

1.  The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes.

Authors:  Miriam A Knoll; Mary Salvatore; Ren Dih Sheu; Abraham D Knoll; Sarah L Kerns; Yeh-Chi Lo; Kenneth E Rosenzweig
Journal:  Quant Imaging Med Surg       Date:  2016-02

2.  Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.

Authors:  M Trovo; N Giaj-Levra; C Furlan; M T Bortolin; E Muraro; J Polesel; E Minatel; R Tedeschi; A R Filippi; F Alongi; U Ricardi
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

3.  Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer.

Authors:  Ayae Kanemoto; Yasuo Matsumoto; Tadashi Sugita
Journal:  Int J Clin Oncol       Date:  2014-11-07       Impact factor: 3.402

4.  Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.

Authors:  J de Castro; M Cobo; D Isla; J Puente; N Reguart; B Cabeza; A Gayete; M Sánchez; M I Torres; J Ferreirós
Journal:  Clin Transl Oncol       Date:  2014-11-06       Impact factor: 3.405

Review 5.  Magnetic resonance imaging with hyperpolarized agents: methods and applications.

Authors:  Erin B Adamson; Kai D Ludwig; David G Mummy; Sean B Fain
Journal:  Phys Med Biol       Date:  2017-04-06       Impact factor: 3.609

6.  Quantitative Analysis of Radiation-Associated Parenchymal Lung Change.

Authors:  Edward Chandy; Adam Szmul; Alkisti Stavropoulou; Joseph Jacob; Catarina Veiga; David Landau; James Wilson; Sarah Gulliford; John D Fenwick; Maria A Hawkins; Crispin Hiley; Jamie R McClelland
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

7.  Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation.

Authors:  Zhen-Yu Hong; Chang Geol Lee; Hyo Sup Shim; Eun Jung Lee; Kwang Hyun Song; Byoung Wook Choi; Jaeho Cho; Michael D Story
Journal:  Lung       Date:  2015-11-12       Impact factor: 2.584

8.  Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC).

Authors:  Rezarta Frakulli; Fabrizio Salvi; Damiano Balestrini; Marcella Palombarini; Ilir Akshija; Silvia Cammelli; Alessio Giuseppe Morganti; Maurizio Zompatori; Giovanni Frezza
Journal:  Transl Lung Cancer Res       Date:  2017-12

9.  Positron Emission Tomography-Based Short-Term Efficacy Evaluation and Prediction in Patients With Non-Small Cell Lung Cancer Treated With Hypo-Fractionated Radiotherapy.

Authors:  Yi-Qing Jiang; Qin Gao; Han Chen; Xiang-Xiang Shi; Jing-Bo Wu; Yue Chen; Yan Zhang; Hao-Wen Pang; Sheng Lin
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 10.  Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Authors:  Percy Lee; Billy W Loo; Tithi Biswas; George X Ding; Issam M El Naqa; Andrew Jackson; Feng-Ming Kong; Tamara LaCouture; Moyed Miften; Timothy Solberg; Wolfgang A Tome; An Tai; Ellen Yorke; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-05       Impact factor: 8.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.